OpenResearchAlpha

bioRxiv · 12 Nov 2026

Dynamic zonal identity is a functional determinant of liver disease

T. Yasaka, H. Inada, C. K. Kim, A. Singh-Varma, S. P. Hu, B. Lehrich, L. Min, M. Poddar, A. Jain, V. Meadows, R. Rai, I. Sipula, F. Bello, D. Gavlock, Y. Tanaka, A. Vandevender, S. Singh, Y. Ren, F.-Y. Qin, S. Uttam, A. Bell, X. Ma, R. Raeman, J.-J. Liu, S. Liu, J. Brown, M. Miedel, M. J. Jurczak, Y.-C. Chiu, S. Angers, N. Khoo, S. P. Monga

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Liver zonation demarcates functional division of labor within the hepatic lobule, yet how zonal identity is reshaped during disease remains poorly understood. We developed RIZLiver, a Bayesian framework that infers zonal identity from gene expression without spatial coordinates. RIZLiver identified progressive loss of zone-3 metabolic identity with advancing stages of metabolic dysfunction-associated steatotic liver disease (MASLD) across independent patient cohorts. Complementary mouse models reveal that perturbing zonal identity shifts susceptibility to diet-induced metabolic injury, linking zone-3 identity to adaptive lipid utilization through lower case beta-catenin and PPARalpha. CTNNB1-mutated hepatocellular carcinomas (HCC) showed an enriched zone-3 and lipid-oxidative phenotype, extending metabolic perturbations beyond MASLD. Pharmacologic reactivation of the zone-3 program shows a therapeutic effect in MASLD. Conversely, interfering with lipid-metabolic addiction in CTNNB1-mutated HCC by targeting PPARalpha; yielded a therapeutic benefit. Our findings identify zonation as a dynamic component of disease phenotype and its restoration as a potential therapy.

Molecular biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (32)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.